ARNA Archives - Page 5 of 6 - Blue Horseshoe Stocks

ACI, OMVE, ENTB & Today’s Extended Watchlist

Arch Coal, Inc. ACI

ACI was a good addition to yesterday’s midday report, and once again, we come through with impeccable timing. We took notice of the fact that the stock is trending up off of its 52-week low, and wasted little time in bringing it to you.

At the time of publication, ACI was slightly in the green, trading at 6.07. ACI went on to finish the day with strength, gaining another 2.5%, closing at 6.19. We will most likely be keeping ACI on our long-term watchlist. Big Board plays can take longer to see gains of the magnitude that we often see in the OTC market. Patience is key!
____

Entest BioMedical Inc. ENTB

Our abiltiy to keep our ear to the street, and time plays with great regularity is almost uncanny. ENTB has proven that, having gained 125% for our readers in just two short trading sessions.

Friday, we added it to the newsletter to watch for a bounce after consolidation from its previous run offered a prime entry at .01 on both Friday, and Monday. On Monday, the stock performed well all day, and closed at the high-of-day; leading us to believe that the momentum could spill over into today.

We will be watching to see where ENTB encounters its next resistance point, which, on the chart, looks like it could be .042; a previous high reached in May. Higher highs and higher lows confirm an uptrend, and we will be looking for a continuation of that into today’s session.

Omni Ventures, Inc. OMVE

As is often the case, we cover plays well in advance of other groups. Such is the case with OMVE as well. After the market close yesterday, our inbox began flooding with several paid newsletters touting OMVE. Fridays low of .13, and yesterdays low of .1435 offered some great entry points to our readers ahead of the crowd. Today we could see an increased amount of activity due to the increased exposure OMVE recieved overnight.

Keep in mind that there are several paid promoters covering this play, and where there are paid promoters, there is likely a third-party selling shares to cover the costs of the campaign, which could put pressure on the stock.

If OMVE gets enough momentum, and can break above resistance points at .20, we could see some additional gains. If you were able to catch the bottom on Friday, or Monday, you could be looking at gains of 30-44% already, at yesterdays close of .187.

Certainly nothing to complain about, and definately time to consider locking in profits if it can’t break through resistance. Moving forward we want to see the support increase, and we would like to see OMVE hold higher highs and higher lows in order to remain on our watchlist.

Yesterday’s News:
PRVCY Expands and Diversifies Customer Base

____

Extended Watchlist:
THWI, AAPT, ICPA, ARNA, JASO

ATRN, ARNA & Today’s Extended Watchlist

Atrinsic, Inc. ATRN

ATRN is a stock we have been covering for quite some time. Some of you may recall the huge run exhibited by the stock earlier this year. Following our alert in January, the stock was trading as low as .012, only to hit a high of .3599 by February for one of our biggest gains all year, totaling 2899% .

As for the present situation, the stock has not been this low since January, and while we do not expect a run of the magnitude we saw before, even a run to the 50DMA of .07, from this level would yield a gain of 100%

We’d like to see the stock hold its key level of support .035, and are looking for a break past .05 (20DMA), which is the first main area of resistance.

____

Arena Pharmaceuticals, Inc. ARNA

ARNA continues to pile up the gains since we began mentioning it back on May 11th , having risen a total of 53% since that time.

We said that the time leading up to the company’s prosposed FDA approval date of 06/27 was going to be interesting, and we were correct. The stock continues to run as we approach zero hour, and we are certainly excited to see the results, and how the stock is affected at that time.

____

Extended Watchlist:

XG (Coming off lows), WEST, ICPA, THWI,

IBIO, ARNA, & Today’s Extended Watchlist

iBio, Inc. IBIO

We’ve been quietly watching IBIO for quite some time. This AMEX stock has been on a consistant downtrend for the past couple of months, and is reaching the point where we felt it was time to begin sniffing for a bottom.

As you can see from the chart below, IBIO has the look of a stock that could be in for quite a recovering run once that ultimate bottom is reached. Shares from this price level could really turn out to be a bargain in the long run.

_____

Arena Pharmaceuticals, Inc. ARNA

ARNA hit a high of 8.65 on Wednesday. That’s a 57% gain from the stock’s low (5.50) following our initial alert. It appears that many investors are, like us, highly anticpating the possibility of ARNA’s FDA Approval.

We’ve already seen sizable gains from ARNA, and certainly would like to keep the stock on our radars for the forseeable future. We will, of course, keep you updated as to the situation.

____

We’d like to congratulate any traders who managed to trade RGIN successfully yesterday, as it was not for the faint of heart. The stock opened at .285 yesterday, and hit a high of .44 before falling into the close at .20. Savvy traders could still have made an intraday gain of 54% early on, and if anyone caught the afternoon bounce from .151 to .249 that came following the high of day, an additional 62% gain was possible.

____

Extended Watchlist:
JASO, VPER, THWI, OMVE

YIPI, ARNA & Today’s Extended Watchlist

Yippy, Inc. YIPI

YIPI recently caught our attention, as a stock that has been on a steady incline for months now. Yesterday’s activity was exciting, and despite the Dow being down over 100 points, YIPI managed a nearly 60% gain.

Any stock that is doing this well during a relatively turbulent time is certainly worth a second look.

The company also had some news out yesterday:

Yippy, Inc. (YIPI) and MuseGlobal to Merge, Offering Unified Access to a Data Cloud of Curated Content

http://www.yippy.com

____

Arena Pharmaceuticals, Inc. ARNA

This stock has appeared on our newsletters before. On May 11th, we stated that “we want to watch this play carefully heading into the month of June, being the target month for FDA approval, as we believe that there could be trading opportunities in the meantime”

We turned out to be correct. In the days following our alert, the stock was trading as low as 5.50, and yesterday reached a high of 7.23, for a 31% gain. Should the company indeed receive the FDA approval it seeks, that 31% could be just a drop in bucket of some much larger gains.

We will keep our eyes peeled for any additional press coming over the wires. In the meantime here’s a link to this morning’s announcement:

Arena and VIVUS Race to Be the First in the Lucrative Anti-Obesity Drug Market

____
Extended Watchlist:

EEGC, CLNO

IDO Security, Inc. | IDOI & Today’s Extended Watchlist

IDO Security, Inc. IDOI

We have seen a bunch of paid newsletters highlighting IDOI over the weekend, a stock that we have been talking about since February 16th.

We mentioned last week that the next key resistance to break was at .50. If, by chance, it doesnt get past that resistance, we would consider it prudent to lock in whatever profits may be on the table at that point.

IDOI is currently receiving a “Strong Buy” Rating at BARCHART.COM

The company also had news out this morning:

NEW YORK, NY, May 14, 2012 (MARKETWIRE via COMTEX) — IDO Security, Inc. (OTCBB: IDOI), developer of the innovative MagShoe(TM) shoe scanning device (SSD), today announced that the Company has completed an order of the MagShoe(TM) 3G, installing multiple units in the Leonardo da Vinci-Fiumicino Airport in Rome, Italy. The tender offer was issued by the Italian Aeroporto di Roma (ADR) through the Company’s local partner, ALCA, to supply and install the MagShoe at the airport’s domestic and international gates.
_____

Extended Watchlist:
ARNA, EMWW, ZNGA,